GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform ...

Penumbra stands to maintain its market lead and possibly increase its market share as the purchasing of the Ruby XL system ...

PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable device.

The US Food and Drug Administration (FDA) has approved Neuspera Medical’s integrated sacral neuromodulation (iSNM) system for ...

Altum Sequencing has developed a tool that uses a simple blood sample for monitoring treatment response in individuals with ...

The European Commission (EC) will restrict Chinese firms from EU government purchases of medical devices exceeding €5m ($5.7m ...

GE HealthCare has announced the renewal of its research partnership with Stanford Medicine, US, focusing on the PET/CT ...

Beset by seemingly endless responsibilities, within the UK's NHS and other healthcare systems globally, burnout among GPs is ...

Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid ...

Qiagen, Incyte have announced a master collaboration agreement to create a diagnostic panel to aid in the treatment of ...

Johnson & Johnson has introduced the TECNIS Odyssey IOL in the Middle East, Canada, and Europe, widening its range of PC-IOLs ...

MedTech Europe has issued a statement calling on European policymakers to exempt medical technologies from any trade tariffs ...